{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:55:19Z","timestamp":1788843319687,"version":"build-2803163510"},"reference-count":53,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tyrosine kinase inhibitors (TKIs) are very effective in treating chronic myelogenous leukemia (CML), but primitive, quiescent leukemia stem cells persist as a barrier to the cure. We performed a comprehensive evaluation of metabolic adaptation to TKI treatment and its role in CML hematopoietic stem and progenitor cell persistence. Using a CML mouse model, we found that glycolysis, glutaminolysis, the tricarboxylic acid cycle, and oxidative phosphorylation (OXPHOS) were initially inhibited by TKI treatment in CML-committed progenitors but were restored with continued treatment, reflecting both selection and metabolic reprogramming of specific subpopulations. TKI treatment selectively enriched primitive CML stem cells with reduced metabolic gene expression. Persistent CML stem cells also showed metabolic adaptation to TKI treatment through altered substrate use and mitochondrial respiration maintenance. Evaluation of transcription factors underlying these changes helped detect increased HIF-1 protein levels and activity in TKI-treated stem cells. Treatment with an HIF-1 inhibitor in combination with TKI treatment depleted murine and human CML stem cells. HIF-1 inhibition increased mitochondrial activity and reactive oxygen species (ROS) levels, reduced quiescence, increased cycling, and reduced the self-renewal and regenerating potential of dormant CML stem cells. We, therefore, identified the HIF-1\u2013mediated inhibition of OXPHOS and ROS and maintenance of CML stem cell dormancy and repopulating potential as a key mechanism of CML stem cell adaptation to TKI treatment. Our results identify a key metabolic dependency in CML stem cells persisting after TKI treatment that can be targeted to enhance their elimination.<\/jats:p>","DOI":"10.1182\/blood.2022018196","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T17:58:31Z","timestamp":1684259911000},"page":"574-588","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":40,"title":["Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-0066","authenticated-orcid":false,"given":"Shaowei","family":"Qiu","sequence":"first","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"},{"name":"2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Sheth","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Yan","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"3Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balu K.","family":"Chacko","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-169X","authenticated-orcid":false,"given":"David K.","family":"Crossman","sequence":"additional","affiliation":[{"name":"5Genomics Core Facility, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth D.","family":"Fortmann","sequence":"additional","affiliation":[{"name":"6Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL"},{"name":"7Medical Scientist Training Program, School of Medicine, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-0586","authenticated-orcid":false,"given":"Sajesan","family":"Aryal","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Rennhack","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Grant","sequence":"additional","affiliation":[{"name":"6Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Welner","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Paterson","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-4675","authenticated-orcid":false,"given":"Adam R.","family":"Wende","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Darley-Usmar","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Mitochondrial Medicine Laboratory, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1593-2612","authenticated-orcid":false,"given":"Rui","family":"Lu","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Locasale","sequence":"additional","affiliation":[{"name":"3Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-2316","authenticated-orcid":false,"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2023081015252112600_bib1","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2023081015252112600_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.stem.2019.02.018","article-title":"Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells","volume":"24","author":"Agarwal","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2023081015252112600_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"2023081015252112600_bib4","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2023081015252112600_bib5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2016-05-714089","article-title":"Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI","volume":"129","author":"Agarwal","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2023081015252112600_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"23","key":"2023081015252112600_bib7","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2023081015252112600_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI79196","article-title":"Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells","volume":"126","author":"Zhang","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2023081015252112600_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"issue":"5","key":"2023081015252112600_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"Zhang","year":"2010","journal-title":"Cancer Cell"},{"issue":"22","key":"2023081015252112600_bib11","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1242\/dev.107086","article-title":"Stem cells and the impact of ROS signaling","volume":"141","author":"Bigarella","year":"2014","journal-title":"Development"},{"issue":"7263","key":"2023081015252112600_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature08313","article-title":"Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation","volume":"461","author":"Owusu-Ansah","year":"2009","journal-title":"Nature"},{"issue":"2","key":"2023081015252112600_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"Foxos are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"},{"issue":"3","key":"2023081015252112600_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"2023081015252112600_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"2023081015252112600_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2023081015252112600_bib17","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"12","key":"2023081015252112600_bib18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"issue":"10","key":"2023081015252112600_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat Med"},{"issue":"7","key":"2023081015252112600_bib20","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1172\/JCI127080","article-title":"SIRT1 regulates metabolism and leukemogenic potential in CML stem cells","volume":"129","author":"Abraham","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"2023081015252112600_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1074\/mcp.M114.044859","article-title":"High-resolution metabolomics with acyl-CoA profiling reveals widespread remodeling in response to diet","volume":"14","author":"Liu","year":"2015","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"2023081015252112600_bib22","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/ac403845u","article-title":"Development and quantitative evaluation of a high-resolution metabolomics technology","volume":"86","author":"Liu","year":"2014","journal-title":"Anal Chem"},{"issue":"8","key":"2023081015252112600_bib23","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/nprot.2008.131","article-title":"Kinetic flux profiling for quantitation of cellular metabolic fluxes","volume":"3","author":"Yuan","year":"2008","journal-title":"Nat Protoc"},{"issue":"6","key":"2023081015252112600_bib24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution","volume":"32","author":"Arguello","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"2023081015252112600_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"1","key":"2023081015252112600_bib26","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","article-title":"Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells","volume":"13","author":"Adamik","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"2023081015252112600_bib27","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.crmeth.2022.100192","article-title":"An integrated toolbox to profile macrophage immunometabolism","volume":"2","author":"Verberk","year":"2022","journal-title":"Cell Rep Methods"},{"issue":"11","key":"2023081015252112600_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat Methods"},{"issue":"11","key":"2023081015252112600_bib29","doi-asserted-by":"crossref","first-page":"e159839","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"19","key":"2023081015252112600_bib30","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-05-1235","article-title":"Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity","volume":"65","author":"Kong","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"2023081015252112600_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2020.01.013","article-title":"Restraining lysosomal activity preserves hematopoietic stem cell quiescence and potency","volume":"26","author":"Liang","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"11","key":"2023081015252112600_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/ars.2014.5941","article-title":"Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment","volume":"21","author":"Ludin","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"2023081015252112600_bib33","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41375-021-01315-0","article-title":"Metabolic alterations mediated by STAT3 promotes drug persistence in CML","volume":"35","author":"Patel","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"2023081015252112600_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"18","key":"2023081015252112600_bib35","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2018-10-808873","article-title":"Mitochondria in the maintenance of hematopoietic stem cells: new perspectives and opportunities","volume":"133","author":"Filippi","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2023081015252112600_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"23","key":"2023081015252112600_bib37","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood-2015-10-677138","article-title":"Adult hematopoietic stem cells lacking Hif-1alpha self-renew normally","volume":"127","author":"Vukovic","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2023081015252112600_bib38","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"issue":"20","key":"2023081015252112600_bib39","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"},{"issue":"11","key":"2023081015252112600_bib40","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1alpha is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"21","key":"2023081015252112600_bib41","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2023081015252112600_bib42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","volume":"130","author":"Cheloni","year":"2017","journal-title":"Blood"},{"issue":"24","key":"2023081015252112600_bib43","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1021\/bi5012892","article-title":"hypoxia inducible factors modulate mitochondrial oxygen consumption and transcriptional regulation of nuclear-encoded electron transport chain genes","volume":"54","author":"Hwang","year":"2015","journal-title":"Biochemistry"},{"issue":"1","key":"2023081015252112600_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","article-title":"HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells","volume":"129","author":"Fukuda","year":"2007","journal-title":"Cell"},{"issue":"9","key":"2023081015252112600_bib45","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00018-019-03039-y","article-title":"Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria","volume":"76","author":"Thomas","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"2023081015252112600_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-019-0206-y","article-title":"HIF1\/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem\/progenitor cells","volume":"7","author":"Wierenga","year":"2019","journal-title":"Cancer Metab"},{"issue":"7","key":"2023081015252112600_bib47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"5","key":"2023081015252112600_bib48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.stem.2013.08.011","article-title":"HIF-2alpha protects human hematopoietic stem\/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Rouault-Pierre","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2023081015252112600_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2013.01.025","article-title":"Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression","volume":"23","author":"Reavie","year":"2013","journal-title":"Cancer Cell"},{"issue":"7607","key":"2023081015252112600_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"issue":"1","key":"2023081015252112600_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-021-01111-4","article-title":"MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies","volume":"14","author":"Ahmadi","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"key":"2023081015252112600_bib52","doi-asserted-by":"crossref","first-page":"590576","DOI":"10.3389\/fcell.2020.590576","article-title":"Molecular crosstalk between MYC and HIF in cancer","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2023081015252112600_bib53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/6\/574\/2070119\/blood_bld-2022-018196-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/6\/574\/2070119\/blood_bld-2022-018196-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:28:31Z","timestamp":1691681311000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/6\/574\/495850\/Metabolic-adaptation-to-tyrosine-kinase-inhibition"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022018196","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}